The Food and Drug Administration has decided to allow generic versions of the most popular form of emergency contraceptive pills to be sold over the counter without age restrictions after all Last July after a decadelong battle and under court order the FDA   of Plan B OneStep which can prevent most pregnancies if taken within  hours of unprotected sex for women who weigh   But in approving the product for sale without prescription the FDA also granted Teva Pharmaceuticals the drugs maker an additional three years of   because it conducted an additional market study on the products use by teenagers Womens health groups who had campaigned hard to make the product more widely available were disappointed in that decision because Plan B OneStep is considerably more expensive than its generic competition  often by at least  But now the FDA has reconsidered In an   to those generic competitors sent earlier this week Kathleen Uhl acting director of the FDAs Office of Generic Drugs wrote that Tevas contention that competitors should not be allowed to sell their products over the counter without age restrictions is too broad In something of a compromise the FDA now says the generic versions of the product must still say on their labels that they are intended for women  years of age or older but they may be sold directly from retail shelves without a requirement to produce proof of age Womens health groups were generally pleased with the action This is a significant leap forward in obtaining full overthecounter status for emergency contraception and we commend the FDA for this decision said Jessica Arons president and CEO of the   Everyone deserves a second chance to get it right including the FDA